BALAMINES

Balaji Amines Share Price

 

 

Invest in Balaji Amines with 3.12X leverage

Invest with MTF

Performance

  • Low
  • ₹1,128
  • High
  • ₹1,139
  • 52 Week Low
  • ₹1,084
  • 52 Week High
  • ₹2,115
  • Open Price₹1,130
  • Previous Close₹1,134
  • Volume4,916

Investment Returns

  • Over 1 Month -19.43%
  • Over 3 Month -24.75%
  • Over 6 Month -23.76%
  • Over 1 Year -45.45%

Smart Investing Starts Here Start SIP with Balaji Amines for Steady Growth!

Invest Now

Balaji Amines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 25.2
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 3,667
  • P/B Ratio
  • Average True Range
  • 36.08
  • EPS
  • 45
  • Dividend Yield
  • 1
  • MACD Signal
  • -60.51
  • RSI
  • 24.95
  • MFI
  • 36.24

Balaji Amines Financials

Balaji Amines Technicals

EMA & SMA

Current Price
₹1,131.80
-1.7 (-0.15%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,206.39
  • 50 Day
  • ₹1,305.44
  • 100 Day
  • ₹1,391.83
  • 200 Day
  • ₹1,504.66

Resistance and Support

1137.83 Pivot Speed
  • R3 1,165.37
  • R2 1,157.63
  • R1 1,145.57
  • S1 1,125.77
  • S2 1,118.03
  • S3 1,105.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Balaji Amines Ltd., is a leading ISO 9001:2015 certified manufacturer of Methylamines, Ethylamines, Specialty Chemicals, and Pharma Excipients. The company is renowned for its advanced manufacturing and R&D capabilities.

Balaji Amines Limited has an operating revenue of Rs. 1,364.35 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of 15% is great, ROE of 8% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 129 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Balaji Amines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-10 Quarterly Results
2025-08-02 Quarterly Results
2025-05-28 Audited Results & Final Dividend (Revised) per share(200%)Final Dividend
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2025-08-01 FINAL Rs.11.00 per share(550%)Final Dividend
View Balaji Amines Dividend History Arrow

Balaji Amines F&O

Balaji Amines Shareholding Pattern

54.59%
0.12%
1.33%
4.53%
0%
34.39%
5.04%

About Balaji Amines

  • NSE Symbol
  • BALAMINES
  • BSE Symbol
  • 530999
  • Managing Director
  • Mr. D Ram Reddy
  • ISIN
  • INE050E01027

Similar Stocks to Balaji Amines

Balaji Amines FAQs

Balaji Amines share price is ₹1,131 As on 05 December, 2025 | 09:52

The Market Cap of Balaji Amines is ₹3667.1 Cr As on 05 December, 2025 | 09:52

The P/E ratio of Balaji Amines is 25.2 As on 05 December, 2025 | 09:52

The PB ratio of Balaji Amines is 2.1 As on 05 December, 2025 | 09:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23